» Articles » PMID: 37127541

Cholesterol Biases the Conformational Landscape of the Chemokine Receptor CCR3: A MAS SSNMR-Filtered Molecular Dynamics Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol directs the pathway of ligand-induced G protein-coupled receptor (GPCR) signal transduction. The GPCR C-C motif chemokine receptor 3 (CCR3) is the principal chemotactic receptor for eosinophils, with roles in cancer metastasis and autoinflammatory conditions. Recently, we discovered a direct correlation between bilayer cholesterol and increased agonist-triggered CCR3 signal transduction. However, the allosteric molecular mechanism escalating ligand affinity and G protein coupling is unknown. To study cholesterol-guided CCR3 conformational selection, we implement comparative, objective measurement of protein architectures by scoring shifts (COMPASS) to grade model structures from molecular dynamics simulations. In this workflow, we scored predicted chemical shifts against 2-dimensional solid-state NMR C-C correlation spectra of U-N,C-CCR3 samples prepared with and without cholesterol. Our analysis of trajectory model structures uncovers that cholesterol induces site-specific conformational restraint of extracellular loop (ECL) 2 and conserved motion in transmembrane helices and ECL3 not observed in simulations of bilayers with only phosphatidylcholine lipids. PyLipID analysis implicates direct cholesterol agency in CCR3 conformational selection and dynamics. Residue-residue contact scoring shows that cholesterol biases the conformational selection of the orthosteric pocket involving Y41, Y113, and E287. Lastly, we observe contact remodeling in activation pathway residues centered on the initial transmission switch, Na pocket, and R in the DRY motif. Our observations have unique implications for understanding of CCR3 ligand recognition and specificity and provide mechanistic insight into how cholesterol functions as an allosteric regulator of CCR3 signal transduction.

Citing Articles

An in silico framework to visualize how cancer-associated mutations influence structural plasticity of the chemokine receptor CCR3.

van Aalst E, Wylie B Protein Sci. 2024; 34(1):e70013.

PMID: 39723881 PMC: 11670309. DOI: 10.1002/pro.70013.


Tools to Score and Predict Cholesterol-Protein Interactions.

Nguyen A, Ondrus A J Med Chem. 2024; 67(23):20765-20775.

PMID: 39616623 PMC: 11647884. DOI: 10.1021/acs.jmedchem.4c01885.


The conformational equilibria of a human GPCR compared between lipid vesicles and aqueous solutions by integrative F-NMR.

Ray A, Jin B, Eddy M bioRxiv. 2024; .

PMID: 39464034 PMC: 11507675. DOI: 10.1101/2024.10.14.618237.


Coordination of bilayer properties by an inward-rectifier K channel is a cooperative process driven by protein-lipid interaction.

van Aalst E, Yekefallah M, A M van Beekveld R, Breukink E, Weingarth M, Wylie B J Struct Biol X. 2024; 9:100101.

PMID: 38883399 PMC: 11176924. DOI: 10.1016/j.yjsbx.2024.100101.


Targeting CCR3 with antagonist SB 328437 sensitizes 5‑fluorouracil‑resistant gastric cancer cells: Experimental evidence and computational insights.

Gutierrez A, Reyes M, Larronde C, Brebi P, Mora-Lagos B Oncol Lett. 2024; 28(1):296.

PMID: 38737977 PMC: 11082837. DOI: 10.3892/ol.2024.14429.


References
1.
Hernando M, Orriss G, Perodeau J, Lei S, Ferens F, Patel T . Solution structure and oligomeric state of the E. coliglycerol facilitator. Biochim Biophys Acta Biomembr. 2020; 1862(5):183191. DOI: 10.1016/j.bbamem.2020.183191. View

2.
Dunn J, Shoda T, Caldwell J, Wen T, Aceves S, Collins M . Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort. J Allergy Clin Immunol. 2020; 145(6):1629-1640.e4. PMC: 7309223. DOI: 10.1016/j.jaci.2020.01.051. View

3.
Zheng Y, Han G, Abagyan R, Wu B, Stevens R, Cherezov V . Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV. Immunity. 2017; 46(6):1005-1017.e5. PMC: 5572563. DOI: 10.1016/j.immuni.2017.05.002. View

4.
Kubatova N, Mao J, Eckert C, Saxena K, Gande S, Wachtveitl J . Light Dynamics of the Retinal-Disease-Relevant G90D Bovine Rhodopsin Mutant. Angew Chem Int Ed Engl. 2020; 59(36):15656-15664. PMC: 7496284. DOI: 10.1002/anie.202003671. View

5.
Xu P, Huang S, Zhang H, Mao C, Zhou X, Cheng X . Structural insights into the lipid and ligand regulation of serotonin receptors. Nature. 2021; 592(7854):469-473. DOI: 10.1038/s41586-021-03376-8. View